Wordt geladen...
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
Gastroesophageal reflux disease is the most common upper gastroenterology disorder in the US. It is associated with a variety of complications and significantly impacts quality of life. Proton pump inhibitors are the most effective treatment. Dexlansoprazole modified release (MR) is a proton pump in...
Bewaard in:
| Gepubliceerd in: | Clin Exp Gastroenterol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4948703/ https://ncbi.nlm.nih.gov/pubmed/27471402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S91602 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|